These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24836142)

  • 1. Signet ring cells in esophageal and gastroesophageal junction carcinomas have a more aggressive biological behavior.
    Nafteux PR; Lerut TE; Villeneuve PJ; Dhaenens JM; De Hertogh G; Moons J; Coosemans WJ; Van Veer HG; De Leyn PR
    Ann Surg; 2014 Dec; 260(6):1023-9. PubMed ID: 24836142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is preoperative chemotherapy followed by surgery the appropriate treatment for signet ring cell containing adenocarcinomas of the esophagogastric junction and stomach?
    Heger U; Blank S; Wiecha C; Langer R; Weichert W; Lordick F; Bruckner T; Dobritz M; Burian M; Springfeld C; Grenacher L; Siewert JR; Büchler M; Ott K
    Ann Surg Oncol; 2014 May; 21(5):1739-48. PubMed ID: 24419755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenocarcinoma of the esophagus with signet ring cell features portends a poor prognosis.
    Enlow JM; Denlinger CE; Stroud MR; Ralston JS; Reed CE
    Ann Thorac Surg; 2013 Dec; 96(6):1927-32. PubMed ID: 23987898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
    Piessen G; Messager M; Leteurtre E; Jean-Pierre T; Mariette C
    Ann Surg; 2009 Dec; 250(6):878-87. PubMed ID: 19855261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma.
    Bekkar S; Gronnier C; Messager M; Robb WB; Piessen G; Mariette C;
    Ann Thorac Surg; 2014 Jan; 97(1):303-10. PubMed ID: 24200394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant Therapy Improves Outcomes in Locally Advanced Signet-Ring-Cell Containing Esophagogastric Adenocarcinomas.
    Heger U; Sisic L; Nienhüser H; Blank S; Hinz U; Haag GM; Ott K; Ulrich A; Büchler MW; Schmidt T
    Ann Surg Oncol; 2018 Aug; 25(8):2418-2427. PubMed ID: 29855828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signet-ring cell or mucinous histology after preoperative chemoradiation and survival in patients with esophageal or esophagogastric junction adenocarcinoma.
    Chirieac LR; Swisher SG; Correa AM; Ajani JA; Komaki RR; Rashid A; Hamilton SR; Wu TT
    Clin Cancer Res; 2005 Mar; 11(6):2229-36. PubMed ID: 15788671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma.
    van Hootegem SJM; Smithers BM; Gotley DC; Brosda S; Thomson IG; Thomas JM; Gartside M; van Lanschot JJB; Lagarde SM; Wijnhoven BPL; Barbour AP
    Ann Surg Oncol; 2019 Aug; 26(8):2375-2384. PubMed ID: 30941657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome.
    Barbour AP; Rizk NP; Gonen M; Tang L; Bains MS; Rusch VW; Coit DG; Brennan MF
    Ann Surg; 2007 Jul; 246(1):1-8. PubMed ID: 17592282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Does early signet ring cell gastric carcinoma carry a worse prognosis?].
    Triboulet JP; Gronnier C; Messager M; Piessen G; Mariette C;
    Bull Acad Natl Med; 2013 Feb; 197(2):443-55; discussion 455-6. PubMed ID: 24919373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signet ring cell adenocarcinomas: different clinical-pathological characteristics of oesophageal and gastric locations.
    Piessen G; Messager M; Lefevre JH; Goéré D; Mabrut JY; Meunier B; Brigand C; Hamy A; Glehen O; Mariette C;
    Eur J Surg Oncol; 2014 Dec; 40(12):1746-55. PubMed ID: 25012732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of post-chemoradiation biopsy in predicting residual esophageal carcinoma in the surgical specimen.
    Yang Q; Cleary KR; Yao JC; Swisher SG; Roth JA; Lynch PM; Komaki R; Ajani JA; Rashid A; Hamilton SR; Wu TT
    Dis Esophagus; 2004; 17(1):38-43. PubMed ID: 15209739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics, biologic behavior, and survival after esophagectomy are similar for adenocarcinoma of the gastroesophageal junction and the distal esophagus.
    Leers JM; DeMeester SR; Chan N; Ayazi S; Oezcelik A; Abate E; Banki F; Lipham JC; Hagen JA; DeMeester TR
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):594-602; discussion 601-2. PubMed ID: 19698841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended surgery for cancer of the esophagus and gastroesophageal junction.
    Lerut T; Coosemans W; Decker G; De Leyn P; Moons J; Nafteux P; Van Raemdonck D
    J Surg Res; 2004 Mar; 117(1):58-63. PubMed ID: 15013715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial.
    Omloo JM; Lagarde SM; Hulscher JB; Reitsma JB; Fockens P; van Dekken H; Ten Kate FJ; Obertop H; Tilanus HW; van Lanschot JJ
    Ann Surg; 2007 Dec; 246(6):992-1000; discussion 1000-1. PubMed ID: 18043101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction.
    Mönig SP; Schröder W; Beckurts KT; Hölscher AH
    Hepatogastroenterology; 2001; 48(41):1231-7. PubMed ID: 11677937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic implications of signet ring cell histology in esophageal adenocarcinoma.
    Yendamuri S; Huang M; Malhotra U; Warren GW; Bogner PN; Nwogu CE; Groman A; Demmy TL
    Cancer; 2013 Sep; 119(17):3156-61. PubMed ID: 23719932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgically Managed Signet Ring Cell Esophageal Carcinomas in the National Cancer Database.
    Sathe TS; Resio BJ; Hoag JR; Monsalve AF; Pathak R; Blasberg JD; Mase V; Dhanasopon A; Boffa DJ
    Ann Thorac Surg; 2020 Jun; 109(6):1656-1662. PubMed ID: 32109449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors of peritoneal recurrence in eso-gastric signet ring cell adenocarcinoma: results of a multicentre retrospective study.
    Honoré C; Goéré D; Messager M; Souadka A; Dumont F; Piessen G; Elias D; Mariette C;
    Eur J Surg Oncol; 2013 Mar; 39(3):235-41. PubMed ID: 23313257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.